The best investment conference of the year starts May 11 - Priority pricing available - save $800. SIC 2020

Shelter in Place

I am writing to you from my home library, since I am no longer working in my office… read article

by Jared Dillian
The 10th Man (March 26, 2020)

It’s Time to Invest in Blue Gold

read article

by Robert Ross
The Weekly Profit (March 25, 2020)

The Beacons Are Lit

In the film version of Tolkien’s Lord of the Rings: Return of the King, there’s a three-minute scene… read article

by John Mauldin
Thoughts from the Frontline (March 20, 2020)

Coronavirus Is Not an Emergency. It’s a War.

This is a short midweek note, something I haven’t done for years. But as we all know, these… read article

by John Mauldin
Thoughts from the Frontline (March 19, 2020)

Coronavirus Stimulus Is an Investment in Life

read article

by Patrick Watson
(March 24, 2020)

Guest Content

The disruption that handed investors 2,718% and 1,066 gains is repeating itself

read article

by Stephen McBride
(March 23, 2020)

Coronavirus Clarifies Priorities

read article

by Patrick Watson
(March 17, 2020)

Guest Content

Important: what to expect in phase 2 of the sell-off

read article

by Stephen McBride
(March 16, 2020)

Welcome to Mauldin Economics

Ever since his breakthrough book, Bull's Eye Investing: Targeting Real Returns in a Smoke and Mirrors Market (Wiley, 2004), best-selling author, analyst, and financial writer John Mauldin has been helping individual investors and institutions develop a clearer understanding of the forces driving the global economy and investment markets.

When you ask anyone in the industry about John Mauldin, it's not unusual for them to quip, "John's got the best Rolodex in the business.”

On behalf of subscribers to Mauldin Economics, John taps into his network either directly or through the reams of high-level research he's privy to on a regular basis, to assist in identifying the smartest investments for today's markets.

These ideas are then carefully screened and evaluated by a team of ace analysts, with only the best of the best brought to the attention of Mauldin Economics subscribers.

This is important to you, because it gives you the equivalent of direct access—just one small step removed—to some of the brightest minds and most successful managers in the world today.

Read more »

Our Investment Products

Mauldin Economics have a range of premium investment newsletters available.

Yield Shark

John Mauldin's personal research team ceaselessly searches for investments offering the best combination of safety, yield, and appreciation to help you dramatically increase your bottom line...
Read more »

Over My Shoulder

Over My Shoulder

Three to four times a week, John Mauldin and Patrick Watson send you the best of the top-level investment and economic research they receive, along with brief summaries and takeaways. Streamlining your research has never been easier...Read more »

Street Freak

Street Freak

Jared Dillian's newest publication brings you trend analysis, trade ideas, and one actionable, easy-to-handle investment recommendation per month... Read more »

The Daily Dirtnap

The Daily Dirtnap

Jared Dillian’s unrestrained daily take on the markets, macro forces, and investor sentiment gives financial pros and sophisticated investors an edge they won’t find anywhere else. Read more »

Macro Income Generator

In the Money

A premium alert service that shows you how to apply current economic trends to an effective growth stock strategy for income investors. Read more »

Healthy Returns

Healthy Returns

Editor Chris Wood and his professional analysts pinpoint profitable investments in the booming healthcare and anti-aging sectors. Read more »

Biotech Millionaire

Biotech Millionaire

This premium alert service, with co-editors Chris Wood and Jake Weber at the helm, focuses on small-cap medical biotech companies with exceptional short-to mid-term profit potential. Their unique C.A.S.H. investing formula—Catalyst, Addressable Market, Science, Hype Potential—ensures that only the most promising candidates make it into the Biotech Millionaire portfolio. Read more »

ETF 20/20

ETF 20/20

If you’re concerned about hidden “gotchas” in ETFs, curious about how ETFs can help you fulfil your investing goals, and want to build a profitable, sustainable, long-term portfolio... then ETF 20/20 is exactly what you’ve been looking for... Read more »

ETF Course

ETF Master Class

Jared Dillian hosts a special ETF Master Class. In this private training, you will gain a much better understanding of how ETFs work as a product and what the implications of the “fine print” mean for you as an investor. Read more »